巨症的医疗治疗:有什么新鲜事?
Pietro Maffei1, Francesca Dassie2
1Department of Medicine (DIMED), Clinica Medica 3, Padua University, Padua, Italy, pietro.maffei@aopd.veneto.it.
Frontiers of hormone research
|November 25, 2024
概括
巨症治疗的目的是使生长激素 (GH) 和胰岛素类生长因子1 (IGF-1) 水平正常化,管理垂体瘤,改善患者的生活质量. 本综述涵盖了当前的护理标准和新兴的药理选择.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 巨症是由多余的生长激素 (GH) 和类似胰岛素的生长因子1 (IGF-1) 引起的,导致全身并发症.
- 治疗目标包括荷尔蒙正常化,垂体质量控制和改善生活质量.
- 多式疗法 (手术,药物,放射治疗) 是标准的,但发生治疗耐药性和复发.
研究的目的:
- 审查目前对壮症的标准治疗方法.
- 介绍新的药理选择和新兴药物用于壮病管理.
- 提供关于壮症药物治疗新进展的概述.
主要方法:
- 对当前壮症治疗方案和药物的文献综述.
- 分析新型治疗策略,包括新配方和药物输送系统.
- 对壮成长症的试验药物的检查.
主要成果:
- 目前的壮症治疗包括手术,药物治疗和放射治疗.
- 新兴的治疗方法包括新的药物配方,输送装置和新型药理学药剂.
- 一些垂体瘤对现有疗法表现出耐药性,需要新的治疗方法.
结论:
- 巨症的管理需要采取全面的方法,以向激素过量和瘤负担.
- 药物治疗的进步为耐药或复发性壮病患者提供了新的希望.
- 对新型药物和配方的持续研究有望改善治疗结果.
更多相关视频
相关概念视频
Myasthenia Gravis: Overview and Treatment
1.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.2K
Hypoglycemia and Glucagon
152
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
152


